Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals

By LabMedica International staff writers
Posted on 02 Feb 2026

Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care. More...

However, many laboratory teams lack the structured training needed to translate these data into actionable insights. Until now, no program had offered a comprehensive overview of how data science can be applied in the clinical laboratory. To address this gap, the Association for Diagnostics & Laboratory Medicine (ADLM) has launched its Data Science in Laboratory Medicine Certificate Program.

ADLM’s Data Science in Laboratory Medicine Certificate Program is designed to help clinical laboratory professionals and pathologists use healthcare data to solve challenging patient problems. Through curated real-world examples, participants learn core data science concepts and practical tools to improve testing algorithms, reduce errors, enhance laboratory operation efficiency, and collaborate more effectively with local data analysts. 

Developed by a team of ADLM’s data science experts, the program provides a foundational overview of key data analytics approaches and how they are applied in laboratory medicine and pathology to strengthen professional expertise and clinical impact. The program covers best practices related to data science, ranging from healthcare data security to mitigation of lab data problems, in addition to the use of machine learning in laboratory workflows.

"We are thrilled to launch this new certificate program for laboratory medicine professionals and pathologists who want to stay ahead of the emerging developments in data science," said ADLM President Dr. Paul J. Jannetto. "Our members saw the need for a professional program that would not only address foundational data science education, but that would also raise awareness of the value of data analytics in laboratory medicine. Healthcare professionals who complete this program will be uniquely distinguished in a field increasingly driven by data and analytics."

Related Links
Association for Diagnostics & Laboratory Medicine (ADLM)


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.